Cognitive-Behavioral Therapy and Pharmacotherapy Augmentation for Generalized Anxiety Disorder: A Pilot Investigation.

Trial Profile

Cognitive-Behavioral Therapy and Pharmacotherapy Augmentation for Generalized Anxiety Disorder: A Pilot Investigation.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Apr 2012

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Apr 2012 Actual patient number amended from 26 to 25 and primary endpoint added as reported by ClinicalTrials.gov.
    • 14 Dec 2011 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 14 Dec 2011 Actual initiation date changed from Mar 2005 to Jan 2005 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top